Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
British Sugar, a subsidiary of Associated British Foods, is the leading sugar producer in the United Kingdom and a critical supplier to the global pharmaceutical industry. The company operates a sophisticated horticultural facility at its Wissington plant, which is one of the world's largest producers of pharmaceutical-grade cannabis. This specialized crop is grown exclusively for Jazz Pharmaceuticals (formerly GW Pharmaceuticals) to produce the active ingredient for Epidyolex, a regulatory-approved treatment for severe forms of epilepsy. By leveraging its expertise in large-scale glasshouse agriculture and circular economy manufacturing, British Sugar provides a highly controlled supply chain for plant-derived medicines. Beyond its pharmaceutical contributions, the company is a major producer of bioethanol, animal feed, and food-grade sugar products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on British Sugar.